CLOs on the Move

Chart SeQual Technologies Inc

www.sequal.com

 
SeQual is committed to a program of continual improvement and expansion of its air separation product line. We constantly strive to identify new opportunities for on-site gas separation that will benefit our customers by improving or cost-reducing their
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Clinical Research Dental Supplies and Services

Founded in 1985, Clinical Research Dental is the proud Canadian distributor for a number of internationally renowned dental manufacturers, including Clinician`s Choice, Ultradent, Bioclear, 3M, Cosmedent, Triodent, Komet and Ribbond. The company is also a leading provider of continuing education programs for dentists, and hosts 40 to 50 seminars and hands-on courses across Canada each year.

Typenex Medical

The Typenex® Medical advantage is connecting with our customers to understand their process needs, then to deliver simple, high-quality products that streamline workflows. Our strength is providing customers the help they need to make sure their process is successful. We think about efficiency and cost-effectiveness, along with patient safety and patient comfort, while providing a quality product. We thoroughly understand the invaluable nature of training and customer service.

Del Mar Medical

Del Mar Medical is a Mount Juliet, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ASI Medical

ASI Medical is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.